Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Steelhead Partners
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Steelhead Partners
from 13F filings
Historical chart of Steelhead Partners investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Steelhead Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Steelhead Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $77B | 60M | 1285.26 |
| 2025-06-30 | $85B | 65M | 1302.17 |
| 2025-03-31 | $50B | 43M | 1154.25 |
| 2024-12-31 | $6.9B | 6.5M | 1067.81 |
| 2024-06-30 | $29B | 27M | 1078.10 |
| 2024-03-31 | $33B | 35M | 939.01 |
| 2023-12-31 | $55B | 55M | 991.18 |
| 2023-09-30 | $51B | 55M | 929.45 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1